News from the University of Chicago
Engineered immune cells could give doctors new precision when fighting tumors.
Researchers at the University of Chicago have developed a modular cancer immunotherapy that can be switched on, off or reprogramed to attack different cancers.
Promising initial testing results, published in Science Advances, demonstrate a “universal” …